Frequency Therapeutics, Inc. FREQ NASDAQ

Frequency Therapeutics, Inc. (FREQ) reported total assets of $113.51M and total liabilities of $62.07M for fiscal year 2025, resulting in total equity of $51.44M.

The company held $75.16M in cash and short-term investments. Total debt stood at $43.49M, with net debt of $21.66M. The Debt-to-Equity (D/E) ratio was 0.85 (moderate).

Current ratio is 6.9, indicating strong short-term liquidity.

Criteria supported by this page:

• HEALTH (75/100, Pass) — Debt-to-Equity of 0.85, current ratio of 6.9 — balance sheet is strong
• MOAT (0/100) — Total assets $113.51M and equity $51.44M support the company's competitive scale
• VALUE (100/100) — Debt-to-Equity 0.85 contributes to the overall valuation risk assessment

Overall SharesGrow Score: 42/100 with 2/7 criteria passed.

SRRK

Scholar Rock Holding Corporation

$49.32

-0.46%

OLMA

Olema Pharmaceuticals, Inc.

$16.49

+1.17%

GLUE

Monte Rosa Therapeutics, Inc.

$18.23

+4.17%

ABSI

Absci Corporation

$3.17

+0.63%

ARMP

Armata Pharmaceuticals, Inc.

$12.06

-6.37%

LCTX

Lineage Cell Therapeutics, Inc.

$1.63

+2.52%

STTK

Shattuck Labs, Inc.

$7.17

+5.75%

ELYM

Eliem Therapeutics, Inc.

$5.11

-0.97%